MannKind Corporation

NASDAQ:MNKD

Biotechnology

Healthcare
$3.95 -0.51%

-$0.02 today

Market cap
$1.27B
Beta
1.11
P/E (TTM)
-50.3
EPS (TTM)
-$0.08
52W Low $2.23High $6.51

Volume 4.08M

Average 5.73M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$18.25M

FY 2025 · Annual

-57.1% YoY

Investing Cash Flow

-$304.80M

FY 2025 · Annual

Financing Cash Flow

$315.10M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(80.93M)(87.4M)(11.94M)27.59M5.86M
Depreciation & Amortization5.47M6.29M5.8M9.04M12.28M
Deferred Income Tax12.64M000(4.97M)
Stock-Based Compensation12.2M017.65M21.36M24.2M
Change in Working Capital(17.73M)(24.05M)14.63M(36.47M)(86.35M)
Accounts Receivables(776K)(11.81M)2.35M2.65M(4.76M)
Inventory(4.08M)(5.67M)4.57M(3.2M)10.4M
Accounts Payables1.37M4.1M(1.47M)(2.79M)(16.71M)
Other Working Capital(14.25M)(10.67M)9.18M(33.14M)(75.27M)
Other Non-Cash Items6.63M24.47M7.96M21M67.23M
Operating Cash Flow(61.71M)(80.7M)34.09M42.51M18.26M
Capital Expenditures(11.47M)(7.59M)(42.44M)(9.69M)(4.57M)
Acquisitions (Net)(56.06M)(15.34M)00(347.74M)
Purchases of Investments(199.13M)(5M)(79.1M)(273.79M)(157.8M)
Sales of Investments59.06M0119.17M58.13M221.72M
Other Investing Activities56.06M32.8M382K128.71M(16.41M)
Investing Cash Flow(151.54M)4.87M(1.99M)(96.65M)(304.8M)
Debt Repayment281.08M(1.09M)(6.86M)(133.17M)325M
Common Stock Issued1.89M22.56M6.89M(6.09M)1.99M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(12.7M)(62K)136.58M1.99M(11.89M)
Financing Cash Flow270.27M21.41M136.61M(137.27M)315.1M
Effect of Forex Changes00000
Net Change in Cash57.02M(54.42M)168.71M(191.4M)28.55M
Free Cash Flow(73.18M)(88.29M)(8.35M)32.82M13.69M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$5.9M
+ D&A$12.3M
+ Stock-Based Comp$24.2M
- Deferred Tax-$5.0M
- Working Capital-$86.3M
+ Other Non-Cash$67.2M
= Operating Cash Flow$18.3M
- Capex-$4.6M
= Free Cash Flow$13.7M

Analysis

FY2025 free cash flow is $13.7M. FCF conversion is 233.5% of net income. Operating cash flow was $18.3M, with capex of -$4.6M. The largest bridge item is Working Capital at -$86.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipSep 28, 2026
4Statement of changes in beneficial ownershipSep 14, 2026

Does MNKD generate free cash flow?

MannKind Corporation (MNKD) generated $13.69M of free cash flow in fiscal 2025.

How much operating cash flow does MNKD produce?

Operating cash flow was $18.25M, before capital expenditures of $4.57M.